alloxan has been researched along with Hyperlipemia in 18 studies
Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alloxan diabetic mice were treated with EGCG." | 5.72 | (-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice. ( Adnan, M; Badraoui, R; Ben-Nasr, H; Chappard, D; El-Feki, A; Gargouri, M; Kausar, MA; Magné, C; Saeed, M; Siddiqui, AJ; Snoussi, M; Soussi, A, 2022) |
| "Alloxan-induced hyperglycemia was accompanied by activation of lipid peroxidation processes with different degree of their completeness depending on the age of experimental animals." | 3.73 | Age-related differences in the degree of lipid peroxidation and state of antioxidant protection under the influence of alloxan. ( Gvozdenko, TA; Yan'kova, VI, 2005) |
| "Alloxan diabetic mice were treated with EGCG." | 1.72 | (-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice. ( Adnan, M; Badraoui, R; Ben-Nasr, H; Chappard, D; El-Feki, A; Gargouri, M; Kausar, MA; Magné, C; Saeed, M; Siddiqui, AJ; Snoussi, M; Soussi, A, 2022) |
| "Alloxan was used to induce diabetes in male Watanabe heritable hyperlipidemic (WHHL) rabbits that were sacrificed 2 and 6 months after the induction of diabetes." | 1.33 | VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. ( Ahtialansaari, T; Babu, M; Bhardwaj, S; Hakumaki, J; Herzig, KH; Kokina, I; Laakso, M; Laitinen, T; Roy, H; Uotila, S; Ylä-Herttuala, S, 2006) |
| "Postprandial dyslipidemia may be a major cause of atherosclerosis in diabetes." | 1.31 | Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. ( Anderton, K; Bennett, A; Collins, P; Owens, D; Phillips, C; Tomkin, GH; White, D, 2002) |
| "Alloxan-diabetic rats were kept on an ordinary or 0." | 1.29 | [Changes in serum lipid and lipoproteins in alloxan-diabetic rats--studies for one year]. ( Arisue, K; Takeuchi, N; Uchida, K, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Soussi, A | 1 |
| Gargouri, M | 1 |
| Magné, C | 1 |
| Ben-Nasr, H | 1 |
| Kausar, MA | 1 |
| Siddiqui, AJ | 1 |
| Saeed, M | 1 |
| Snoussi, M | 1 |
| Adnan, M | 1 |
| El-Feki, A | 1 |
| Chappard, D | 1 |
| Badraoui, R | 1 |
| Umar, U | 1 |
| Ahmed, S | 1 |
| Iftikhar, A | 1 |
| Iftikhar, M | 1 |
| Majeed, W | 1 |
| Liaqat, A | 1 |
| Shahzad, S | 1 |
| Abbas, M | 1 |
| Mehmood, T | 1 |
| Anwar, F | 1 |
| Elseweidy, MM | 1 |
| Elnagar, GM | 1 |
| M Elsawy, M | 1 |
| Ali, AA | 1 |
| Zein, N | 1 |
| El-Tantawy, WH | 1 |
| Haleem, EN | 1 |
| Kaimal, S | 1 |
| Sujatha, KS | 1 |
| George, S | 1 |
| Volchegorskiĭ, IA | 1 |
| Rassokhina, LM | 1 |
| Miroshnichenko, IIu | 1 |
| Pan, J | 1 |
| Liu, G | 1 |
| Liu, H | 1 |
| Qiu, Z | 1 |
| Chen, L | 1 |
| Kameswararao, B | 1 |
| Kesavulu, MM | 1 |
| Apparao, C | 1 |
| OHE, K | 1 |
| TAGUCHI, K | 1 |
| INOUE, T | 1 |
| KATSURA, E | 1 |
| COURTICE, FC | 2 |
| MUNOZ-MARCUS, M | 2 |
| GARLICK, DG | 1 |
| el-Batran, SA | 1 |
| el-Shenawy, SM | 1 |
| Nofal, SM | 1 |
| Abdel-Salam, OM | 1 |
| Arbid, MS | 1 |
| Yan'kova, VI | 1 |
| Gvozdenko, TA | 1 |
| Roy, H | 1 |
| Bhardwaj, S | 1 |
| Babu, M | 1 |
| Kokina, I | 1 |
| Uotila, S | 1 |
| Ahtialansaari, T | 1 |
| Laitinen, T | 1 |
| Hakumaki, J | 1 |
| Laakso, M | 1 |
| Herzig, KH | 1 |
| Ylä-Herttuala, S | 1 |
| Smith, SL | 1 |
| Novotný, M | 1 |
| Nakakimura, H | 1 |
| Mizuno, K | 1 |
| Arisue, K | 1 |
| Uchida, K | 1 |
| Takeuchi, N | 1 |
| Phillips, C | 1 |
| Bennett, A | 1 |
| Anderton, K | 1 |
| Owens, D | 1 |
| Collins, P | 1 |
| White, D | 1 |
| Tomkin, GH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Bariatric Surgery on Circulating Inflammatory and Pro-vascular Progenitor Cell Populations.[NCT04132531] | 38 participants (Actual) | Observational | 2018-05-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 other studies available for alloxan and Hyperlipemia
| Article | Year |
|---|---|
(-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Hyperglyce | 2022 |
Phenolics Extracted from
Topics: Alloxan; Animals; bcl-2-Associated X Protein; Biomarkers; Blood Glucose; Caspase 3; Diabetes Mellitu | 2023 |
Losartan and azelastine either alone or in combination as modulators for endothelial dysfunction and platelets activation in diabetic hyperlipidemic rats.
Topics: Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Blood Platelets; Diabete | 2020 |
Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Flow Cytometry; Glutathion | 2014 |
Hypolipidaemic and antioxidant effects of fruits of Musa AAA (Chenkadali) in alloxan induced diabetic rats.
Topics: Alanine Transaminase; Alloxan; Animals; Antioxidants; Cholesterol; Diabetes Mellitus, Experimental; | 2010 |
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; D | 2011 |
[Effects of artemisia capillaris on blood glucose and lipid in mice].
Topics: Alloxan; Animals; Artemisia; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Drugs, Chi | 1998 |
Evaluation of antidiabetic effect of Momordica cymbalaria fruit in alloxan-diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, | 2003 |
STUDIES ON THE TURNOVER OF LIPIDS IN ALLOXAN-DIABETIC RATS.
Topics: Acetates; Alloxan; Animals; Carbon Isotopes; Cholesterol; Diabetes Mellitus, Experimental; Fatty Aci | 1964 |
THE COMPOSITION OF THE PLASMA LIPOPROTEINS IN EXPERIMENTAL HYPERLIPAEMIA INDUCED BY TRITON WR-1339, CORTISONE, ALLOXAN AND HAEMORRHAGE IN RABBITS.
Topics: Alloxan; Animals; Blood Proteins; Cholesterol; Cortisone; Hemorrhage; Hyperlipidemias; Lipoproteins; | 1964 |
THE PERMEABILITY OF THE BLOOD CAPILLARIES OF THE LEG TO THE LIPOPROTEINS IN VARIOUS HYPERLIPAEMIC STATES IN THE RABBIT.
Topics: Alloxan; Animals; Arteriosclerosis; Burns; Capillaries; Capillary Permeability; Cortisone; Hyperlipi | 1964 |
Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Blood Proteins; Carbamates; Cholesterol, LDL; Diabetes Mellitus, Ex | 2004 |
Age-related differences in the degree of lipid peroxidation and state of antioxidant protection under the influence of alloxan.
Topics: Aging; Alloxan; Animals; Antioxidants; Diabetes Mellitus, Experimental; Hyperglycemia; Hyperlipidemi | 2005 |
VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits.
Topics: Alloxan; Animals; Atherosclerosis; Diabetes Mellitus, Experimental; Disease Models, Animal; Hyperlip | 2006 |
Studies of hyperlipidemia in drug-induced diabetic rats by high-performance liquid chromatography.
Topics: Alloxan; Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Hyperlipide | 1980 |
Studies on lipid peroxidation in biological systems. II. Hyperlipoperoxidemia in mice induced by alloxan.
Topics: Alloxan; Animals; Blood Glucose; Carbon Tetrachloride; Dose-Response Relationship, Drug; Hyperlipide | 1980 |
[Changes in serum lipid and lipoproteins in alloxan-diabetic rats--studies for one year].
Topics: Alloxan; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Hyperlipidemias; Insu | 1994 |
Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.
Topics: Alloxan; Animals; Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Carrier Proteins; Ch | 2002 |